UK markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.22-0.13 (-2.05%)
At close: 04:00PM EDT
6.15 -0.07 (-1.13%)
After hours: 06:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.35
Open6.20
Bid6.15 x 1200
Ask7.10 x 900
Day's range6.11 - 6.39
52-week range1.99 - 41.00
Volume85,091
Avg. volume583,790
Market cap58.623M
Beta (5Y monthly)1.43
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript

    Good morning, everyone, and thank you for joining today to discuss our second quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing its second quarter 2022 financial results. The press release and accompanying presentation are available on the company's website TherapeuticsMD in the investors and media section.

  • Zacks

    TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates

    TherapeuticsMD (TXMD) delivered earnings and revenue surprises of 29.28% and 23.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Motley Fool

    TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call Transcript

    Thank you for joining us for TherapeuticsMD's first quarter 2020 financial results conference call. Good afternoon, everyone, and thank you for joining today to discuss our first quarter financial results and business update. This afternoon, TherapeuticsMD issued a press release announcing its first quarter 2022 financial results.